<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/8047" />
  <subtitle />
  <id>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/8047</id>
  <updated>2026-05-16T23:45:21Z</updated>
  <dc:date>2026-05-16T23:45:21Z</dc:date>
  <entry>
    <title>A Descriptive Analysis of Peripheral Arterial Disease: Clinical Profile, Comorbidities, And Management Outcomes</title>
    <link rel="alternate" href="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12657" />
    <author>
      <name>Vinojan, S.</name>
    </author>
    <author>
      <name>Thananchayan, H.</name>
    </author>
    <author>
      <name>Niranjan, N.</name>
    </author>
    <id>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12657</id>
    <updated>2026-05-15T06:05:22Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: A Descriptive Analysis of Peripheral Arterial Disease: Clinical Profile, Comorbidities, And Management Outcomes
Authors: Vinojan, S.; Thananchayan, H.; Niranjan, N.
Abstract: Background: &#xD;
Peripheral Arterial Disease (PAD) presents a significant burden, particularly in patients with  multiple comorbidities, highlighting the need for early diagnosis and timely intervention. &#xD;
Objectives: &#xD;
To describe the clinical profile, comorbidities, anatomical distribution, interventions, and  outcomes in patients with PAD. &#xD;
Method: &#xD;
A prospective descriptive study of 57 PAD patients admitted to the professorial unit of Teaching  Hospital Jaffna. Data were collected from clinical records and BHTs. &#xD;
Results: &#xD;
The mean age was 66 years. Diabetes Mellitus was the most common comorbidity (73.7%, n = 42), followed by hypertension (31.6%, n = 18), ischemic heart disease (19.3%, n = 11), and  dyslipidaemia (15.8%, n = 9). Tissue loss is the commonest presentation for Chronic Limb Threatening Ischemia (CLTI). Among 41 patients with imaging data, tibial vessels (46.3%, n = 19) and superficial femoral artery (39%, n=16) were most commonly involved. Iliac (n = 1),  combined SFA and tibial (n = 3), and foot arch disease (n = 2) were less frequent. Definitive  procedures were performed in 78.9% (n = 45); angioplasty (54.4%, n = 31) was most common,  followed by femoral-popliteal bypass (19.3%, n = 11). Others were managed conservatively or  with wound care. Outcomes included wound healing in 22.8% (n = 13), healing in progress in  10.5% (n=6), and major amputations in 7% (n = 4). There were 3 deaths (5.3%) due to  myocardial infarction. Most others showed clinical improvement. Follow-up revealed 2  defaults, 1 symptomatic improvement, 2 reinterventions, 4 minor amputations (toe/forefoot), 2  recurrent wounds, 1 redo bypass, 1 post-op angioplasty, 1 aneurysm repair, and 1 awaiting  bypass. &#xD;
Conclusion: &#xD;
PAD primarily affects elderly diabetics, with CLTI as the commonest presentation. Tibial and  femoral arteries were most involved. Angioplasty was the mainstay of treatment. Despite  encouraging outcomes, complications emphasize the need for early intervention and structured  follow-up.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Radial artery aneurysm in the anatomical snuff box: a rare case with uncertain aetiology</title>
    <link rel="alternate" href="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12003" />
    <author>
      <name>Thananchyan, H.</name>
    </author>
    <author>
      <name>Satchithanantham, V.</name>
    </author>
    <author>
      <name>Mahilrajan, G.</name>
    </author>
    <author>
      <name>Sivamayuran, V.</name>
    </author>
    <id>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12003</id>
    <updated>2026-01-13T10:01:34Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Radial artery aneurysm in the anatomical snuff box: a rare case with uncertain aetiology
Authors: Thananchyan, H.; Satchithanantham, V.; Mahilrajan, G.; Sivamayuran, V.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus</title>
    <link rel="alternate" href="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432" />
    <author>
      <name>Hamoda, T.</name>
    </author>
    <author>
      <name>Shah, R.</name>
    </author>
    <author>
      <name>Mostafa, T.</name>
    </author>
    <author>
      <name>Germar-Michael, P.</name>
    </author>
    <author>
      <name>Atmoko, W.</name>
    </author>
    <author>
      <name>Balagobi, B.</name>
    </author>
    <id>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432</id>
    <updated>2025-07-24T06:15:16Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus
Authors: Hamoda, T.; Shah, R.; Mostafa, T.; Germar-Michael, P.; Atmoko, W.; Balagobi, B.
Abstract: Purpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure,&#xD;
is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is&#xD;
marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial&#xD;
need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice&#xD;
&#xD;
recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can glob-&#xD;
ally help guide practitioners in their practice.&#xD;
&#xD;
Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, di-&#xD;
agnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through&#xD;
&#xD;
the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were&#xD;
graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.”&#xD;
Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.”&#xD;
&#xD;
Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, in-&#xD;
cluding 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel&#xD;
&#xD;
of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experi-&#xD;
ence in managing NOA.&#xD;
&#xD;
Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide&#xD;
comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large&#xD;
&#xD;
worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly inte-&#xD;
grated into the daily global practice, offering practitioners a clear framework for managing NOA.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Assessment of Urinary Stone Chemical Compositions and Prevalence of Metabolic Disorders among Urolithiasis Patients in Northern Sri Lanka: A Prospective Study</title>
    <link rel="alternate" href="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11283" />
    <author>
      <name>Balagobi, B.</name>
    </author>
    <author>
      <name>Rajendra, S.</name>
    </author>
    <author>
      <name>Vinojan, S.</name>
    </author>
    <author>
      <name>Sarma, S.T.</name>
    </author>
    <author>
      <name>Sripandurangana, R.</name>
    </author>
    <author>
      <name>Varothayan, S.</name>
    </author>
    <author>
      <name>Vishnuja, S.</name>
    </author>
    <id>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11283</id>
    <updated>2025-06-03T06:44:37Z</updated>
    <published>2024-01-01T00:00:00Z</published>
    <summary type="text">Title: Assessment of Urinary Stone Chemical Compositions and Prevalence of Metabolic Disorders among Urolithiasis Patients in Northern Sri Lanka: A Prospective Study
Authors: Balagobi, B.; Rajendra, S.; Vinojan, S.; Sarma, S.T.; Sripandurangana, R.; Varothayan, S.; Vishnuja, S.</summary>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

